Skip to main navigation Discovering the next generation of precision medicines Overview News & Presentations Stock Information Governance SEC Filings ESG Investor Resources Company Overview We are a clinical-stage precision medicines company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of disparate technologies, we aim to push the boundaries of what’s possible in drug discovery. Our Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable. Our initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease. Press Releases Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights November 10, 2021 Relay Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate Highlights November 4, 2021 View all Recent Events Relay Therapeutics Corporate Update Call – Data Presentations at AACR-NCI-EORTC Molecular Targets Conference Oct 8, 2021 from 12:30 PM to 1:30 PM EDT Click Here for Webcast Relay Therapeutics at the JMP Securities Life Science Conference Jun 17, 2021 from 10:30 AM to 10:55 AM EDT Click Here for Webcast Relay Therapeutics at the Goldman Sachs 42nd Annual Healthcare Conference Jun 10, 2021 from 3:50 PM to 4:30 PM EDT Click Here for Webcast View all -- (%) Data Provided by Refinitiv. Minimum 15 minutes delayed. Who We Are About Us Dynamo Platform Pipeline Patients Investors & Media Careers Contact Relay Therapeutics 399 Binney Street, 2nd Floor Cambridge, MA 02139 info@relaytx.com (617) 370-8837 © Relaytx 2021 Privacy Policy Terms of Use